RMCM
CLX icon

Reynders McVeigh Capital Management’s Clorox CLX Stock Holding History

Reynders McVeigh Capital Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,314
Closed -$233K – 199
2025
Q4 		$233K Sell
2,314
-60
-3% -$6.51K 0.01% 182
2025
Q3 		$293K Hold
2,374
– – 0.01% 169
2025
Q2 		$285K Buy
2,374
+170
+8% +$22.7K 0.01% 170
2025
Q1 		$325K Sell
2,204
-20
-0.9% -$3.05K 0.02% 161
2024
Q4 		$361K Hold
2,224
– – 0.02% 157
2024
Q3 		$362K Sell
2,224
-55
-2% -$8.15K 0.02% 160
2024
Q2 		$311K Sell
2,279
-203
-8% -$28.2K 0.02% 161
2024
Q1 		$381K Sell
2,482
-125
-5% -$18.7K 0.02% 151
2023
Q4 		$372K Sell
2,607
-720
-22% -$96K 0.02% 157
2023
Q3 		$436K Hold
3,327
– – 0.03% 137
2023
Q2 		$529K Sell
3,327
-450
-12% -$72.6K 0.03% 131
2023
Q1 		$598K Sell
3,777
-1,020
-21% -$153K 0.04% 122
2022
Q4 		$673K Sell
4,797
-725
-13% -$103K 0.05% 115
2022
Q3 		$709K Sell
5,522
-1,985
-26% -$286K 0.06% 108
2022
Q2 		$1.06M Sell
7,507
-800
-10% -$114K 0.08% 94
2022
Q1 		$1.16M Sell
8,307
-2,407
-22% -$369K 0.07% 99
2021
Q4 		$1.87M Sell
10,714
-530
-5% -$88.4K 0.11% 84
2021
Q3 		$1.86M Sell
11,244
-35
-0.3% -$6.03K 0.11% 81
2021
Q2 		$2.03M Sell
11,279
-2,495
-18% -$455K 0.12% 81
2021
Q1 		$2.66M Buy
13,774
+1,825
+15% +$351K 0.18% 68
2020
Q4 		$2.41M Sell
11,949
-130
-1% -$26.9K 0.16% 68
2020
Q3 		$2.54M Sell
12,079
-1,010
-8% -$225K 0.2% 63
2020
Q2 		$2.87M Sell
13,089
-1,570
-11% -$314K 0.25% 60
2020
Q1 		$2.54M Sell
14,659
-3,570
-20% -$590K 0.29% 58
2019
Q4 		$2.8M Sell
18,229
-1,195
-6% -$179K 0.27% 58
2019
Q3 		$2.95M Buy
19,424
+75
+0.4% +$11.9K 0.32% 57
2019
Q2 		$2.96M Buy
19,349
+965
+5% +$147K 0.32% 57
2019
Q1 		$2.95M Buy
18,384
+420
+2% +$65.2K 0.33% 55
2018
Q4 		$2.77M Buy
17,964
+2,465
+16% +$384K 0.37% 55
2018
Q3 		$2.33M Buy
15,499
+595
+4% +$84.5K 0.27% 64
2018
Q2 		$2.02M Buy
14,904
+687
+5% +$84.8K 0.26% 67
2018
Q1 		$1.89M Buy
14,217
+115
+0.8% +$15.4K 0.24% 64
2017
Q4 		$2.1M Sell
14,102
-135
-0.9% -$18.4K 0.28% 64
2017
Q3 		$1.88M Sell
14,237
-341
-2% -$45.8K 0.24% 67
2017
Q2 		$1.94M Sell
14,578
-395
-3% -$53.3K 0.26% 69
2017
Q1 		$2.02M Sell
14,973
-145
-1% -$18.8K 0.28% 70
2016
Q4 		$1.81M Hold
15,118
– – 0.26% 72
2016
Q3 		$1.89M Sell
15,118
-50
-0.3% -$6.55K 0.28% 64
2016
Q2 		$2.1M Sell
15,168
-1,250
-8% -$162K 0.3% 64
2016
Q1 		$2.07M Sell
16,418
-514
-3% -$65.3K 0.31% 64
2015
Q4 		$2.15M Sell
16,932
-151
-0.9% -$18.7K 0.35% 50
2015
Q3 		$1.97M Buy
17,083
+1,395
+9% +$157K 0.34% 52
2015
Q2 		$1.63M Buy
15,688
+290
+2% +$31.3K 0.27% 62
2015
Q1 		$1.7M Sell
15,398
-490
-3% -$53.2K 0.29% 57
2014
Q4 		$1.66M Sell
15,888
-850
-5% -$85K 0.29% 57
2014
Q3 		$1.61M Buy
16,738
+241
+1% +$21.8K 0.31% 55
2014
Q2 		$1.51M Buy
16,497
+654
+4% +$58.6K 0.34% 56
2014
Q1 		$1.39M Buy
15,843
+1,976
+14% +$173K 0.33% 61
2013
Q4 		$1.29M Buy
13,867
+175
+1% +$15.8K 0.32% 61
2013
Q3 		$1.12M Buy
13,692
+500
+4% +$42.2K 0.31% 62
2013
Q2 		$1.1M Buy
+13,192
New +$1.14M 0.33% 65

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Reynders McVeigh Capital Management's CLX Position: Q1 2026 in Review

Reynders McVeigh Capital Management sold out of Clorox (CLX) in Q1 2026, closing a stake of 2,314 shares — an estimated $233K sold.

Reynders McVeigh Capital Management first reported a position in CLX in Q2 2013 and held it in 51 quarters. The position peaked at $2.96M in Q2 2019. 1,084 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Reynders McVeigh Capital Management reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 2,314 Clorox shares in Q1 2026, an estimated $233K.
  • Reynders McVeigh Capital Management first reported a position in Clorox in Q2 2013 and held it in 51 quarters.
  • Reynders McVeigh Capital Management's Clorox position peaked at $2.96M in Q2 2019.
  • 1,084 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.